Register | Login

The combination of two agents (voriconazole plus echinocandin) is currentlyZafrani and Azoulay BMC Infectious Diseases 2014, 14:512 http://www.biomedcentral.com/1471-2334/14/Page 7 ofrecommended only in salvage therapy for pulmonary aspergillosis. However, an unpublished trial has proven no benefit of combination of antifungal therapy. The combination of caspofungin plus voriconazole is also a tre



Visitbookmarks is an open source content management system that lets you easily create your own social network, where you share your content in online. Blog Visitbookmarks.

Username:

Password:

Remember: